Published in Int J Pediatr Otorhinolaryngol on January 25, 1999
Lipomas of the oral cavity: clinicopathological and immunohistochemical study of 24 cases and review of the literature. Indian J Otolaryngol Head Neck Surg (2014) 0.96
Intramuscular lipoma: a review of the literature. Orthop Rev (Pavia) (2014) 0.82
Intramuscular benign lipoma of the sternocleidomastoid muscle: a rare cause of neck mass. Eur Arch Otorhinolaryngol (2004) 0.80
Treatment for intramuscular lipoma frequently confused with sarcoma: a 6-year restrospective study and literature review. Biomed Res Int (2014) 0.75
Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement? Leukemia (2005) 3.23
Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON. Lancet (1992) 1.92
An uncommon association: celiac disease and dermatomyositis in adults. Clin Exp Rheumatol (2001) 1.49
Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol (1998) 1.44
Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. J Laryngol Otol (2006) 1.33
Overexpression of cyclin D2 in chronic B-cell malignancies. Blood (1995) 1.26
Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis. Cell Death Differ (2009) 1.26
Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood (1998) 1.21
Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol (1998) 1.18
[Degree of granularity of the atrial cardiocytes. Morphometric study in rats subjected to different types of water and sodium load (author's transl)]. Pathol Biol (Paris) (1976) 1.17
The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score. Blood (2000) 1.12
Quality of life in head and neck cancers patients: predictive factors, functional and psychosocial outcome. Eur Arch Otorhinolaryngol (2008) 1.09
T-lymphocyte colonies in the lymphoproliferative disorders. Immunology (1978) 1.09
Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia. Blood (1998) 1.04
Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity. Dev Pharmacol Ther (1993) 1.02
Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. Blood (1999) 1.01
Postoperative analgesia with i.v. propacetamol and ketoprofen combination after disc surgery. Can J Anaesth (1997) 0.99
A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood (1998) 0.97
A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia. Br J Cancer (2006) 0.96
Q fever in French Guiana: new trends. Emerg Infect Dis (1998) 0.96
Preconditioning prevents chronic reperfusion-induced coronary endothelial dysfunction in rats. Am J Physiol (1996) 0.95
Epidemic Pseudomonas aeruginosa serotype O16 bacteremia in hematology-oncology patients. J Clin Microbiol (1989) 0.95
Polymyositis, cranial neuropathy, autoimmune hepatitis, and hepatitis C. Ann Rheum Dis (2000) 0.95
Long-term impact of subclinical inflammation diagnosed by protocol biopsy one year after renal transplantation. Am J Transplant (2011) 0.94
Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development. Antimicrob Agents Chemother (2005) 0.94
Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit. Biol Neonate (1998) 0.93
[Massive poisoning by African bee stings]. Presse Med (1998) 0.93
[Role of endothelium in radiation-induced normal tissue damages]. Ann Cardiol Angeiol (Paris) (2008) 0.92
[Spheno-ethmoidal rhinoscleroma. Report of a case and review of the literature]. Ann Otolaryngol Chir Cervicofac (1998) 0.91
Relationship between subcellular localisation of Foscan and caspase activation in photosensitised MCF-7 cells. Br J Cancer (2007) 0.90
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes--a possible protective mechanism against atherothrombosis. Thromb Haemost (2000) 0.90
The presence within single K-562 cells of erythropoietic and granulopoietic differentiation markers. Blood (1981) 0.89
Acceptor specificity and tissue distribution of three human alpha-3-fucosyltransferases. Eur J Biochem (1990) 0.89
Acquired cholesteatoma in children: strategies and medium-term results. Eur Ann Otorhinolaryngol Head Neck Dis (2012) 0.88
Homoharringtonine: an effective new natural product in cancer chemotherapy. Bull Cancer (1995) 0.88
Spontaneous remission in adult acute leukemia. Cancer (1985) 0.88
JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia. Blood (2001) 0.88
Endoscopic revision of external dacryocystorhinostomy failure. Rhinology (2010) 0.87
Changes in growth factor and cytokine mRNA levels after hepatectomy in rat with CCl(4)-induced cirrhosis. Am J Physiol (1999) 0.86
Functional assay of multidrug resistant cells using JC-1, a carbocyanine fluorescent probe. Leukemia (1997) 0.86
[Ataxia and deafness secondary to meningitis in children: the role of labyrinth diseases]. Arch Fr Pediatr (1975) 0.86
Selective reinnervation of the abductor and adductor muscles of the canine larynx after recurrent nerve paralysis. Ann Otol Rhinol Laryngol (1989) 0.85
Pregnancy during myelosuppressive treatment for chronic myelogenous leukemia. Br J Haematol (1992) 0.85
Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French Drug Resistance Network. Cytometry (1998) 0.85
Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques. Leukemia (1994) 0.85
Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Br J Haematol (1996) 0.85
Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature. Br J Haematol (2000) 0.85
Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients. Br J Haematol (1994) 0.84
Ultrastructural localization of peroxidases in 'undifferentiated' blasts during the blast crisis of chronic granulocytic leukaemia. Br J Haematol (1979) 0.84
Experimental reinnervation of a strap muscle with a few roots of the phrenic nerve in rabbits. Ann Otol Rhinol Laryngol (1999) 0.84
Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant. Bone Marrow Transplant (2000) 0.84
Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia (1992) 0.84
Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model. J Antimicrob Chemother (2005) 0.84
Basaloid squamous cell carcinoma of the head and neck: report of 18 cases. J Laryngol Otol (2011) 0.83
Comparison between anatomy and resistance of upper airway in normal subjects, snorers and OSAS patients. Respir Physiol (2002) 0.83
Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome? Rheumatology (Oxford) (2001) 0.82
[Neuromyopathy and atypical cutaneous syndrome associated with cancer of the esophagus]. Sem Hop (1969) 0.82
[Pregnancy and hematologic malignancies: a therapeutic approach]. Bull Cancer (1994) 0.82
[Benign sub-periosteal osteoblastoma of the nasal cavity. histological and ultrastructural study of a case]. Ann Pathol (1985) 0.82
Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Res (1993) 0.82
Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia (1995) 0.82
[Ewing's sarcoma of the head and neck: a case report]. Ann Otolaryngol Chir Cervicofac (2002) 0.82
Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways. Biochem Biophys Res Commun (2006) 0.82
Does medical treatment of lymphedema act by increasing lymph flow? Vasa (1989) 0.82
Up-regulated expression of HGF in rat liver cells after experimental endotoxemia: a potential pathway for enhancement of liver regeneration. Growth Factors (2001) 0.82
Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13. Br J Haematol (1995) 0.81
Lung resistance protein (LRP) gene expression in adult acute myeloid leukemia: a critical evaluation by three techniques. Leukemia (1998) 0.81
Granulopoietic differentiation in AML blasts in culture. Blood (1981) 0.81
Magnetic resonance spectroscopy of cellular lipid extracts from sensitive, resistant and reverting K562 cells and flow cytometry for investigating the P-glycoprotein function in resistance reversion. NMR Biomed (2000) 0.81
[Acquired ichthyosis in the acquired immunodeficiency syndrome]. Presse Med (1984) 0.81
Upper airway resistance during progressive hypercapnia and progressive hypoxia in normal awake subjects. Respir Physiol (2001) 0.81
Expression of ABH and X (Lex) antigens on platelets and lymphocytes. Blood (1988) 0.80
Peroxidase activity in circulating mast cells in blast crisis of chronic granulocytic leukemia. Comparative studies with basophils and cutaneous mast cells. Am J Clin Pathol (1986) 0.80
Gaucher's disease with monoclonal gammopathy. Significance of splenic plasmacytosis. Scand J Haematol (1982) 0.80
Spontaneous remission in acute myeloid leukaemia. Br J Haematol (1994) 0.80
Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure. Leukemia (2001) 0.80
Optimization of whispering gallery resonator design for biosensing applications. Opt Express (2015) 0.80
Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia. Thromb Haemost (1995) 0.80
Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatment. Ann Hematol (1997) 0.80
Clinical effects on CA 15-3 level of cyclosporin A as a chemosensitiser in chemoresistant metastatic breast cancer. Eur J Cancer (1993) 0.80
[Melanoma of the nasal fossae and sinuses, apropos of a series of 7 cases]. Rev Laryngol Otol Rhinol (Bord) (1990) 0.80
Effect of the multidrug inhibitor GG918 on drug sensitivity of human leukemic cells. Leukemia (1997) 0.80
In vitro culture of clonogenic leukaemic cells in acute myeloid leukaemia: growth pattern and drug sensitivity. Br J Haematol (1983) 0.80